Reuters logo
BRIEF-Momenta Pharmaceuticals Q1 loss per share $0.46
May 2, 2017 / 12:16 PM / 7 months ago

BRIEF-Momenta Pharmaceuticals Q1 loss per share $0.46

May 2 (Reuters) - Momenta Pharmaceuticals Inc

* Momenta pharmaceuticals reports first quarter 2017 financial results

* Q1 revenue $26.6 million versus i/b/e/s view $24.5 million

* Q1 loss per share $0.46

* Q1 earnings per share view $-0.66 -- Thomson Reuters I/B/E/S

* Momenta pharmaceuticals says reiterating non-gaap operating expense guidance of approximately $200 - $240 million for 2017 and $50 - $60 million for q2 of 2017

* Says expects to recognize $50 million upfront payment from csl as revenue in second half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below